Literature DB >> 9802945

Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis.

A C Malmborg1, D B Shultz, F Luton, K E Mostov, E Richly, P S Leung, G D Benson, A A Ansari, R L Coppel, M E Gershwin, J Van de Water.   

Abstract

Primary biliary cirrhosis (PBC) is a chronic autoimmune liver disease of unknown etiology characterized by high-titer anti-mitochondrial antibodies. The major autoantigen has been identified as the E2 subunit of the pyruvate dehydrogenase complex (PDC-E2). The fact that PDC-E2 is present in all nucleated cells, but autoimmune damage is confined to biliary epithelial cells, prompted us to investigate the possibility that mucosally-derived IgA may be pathogenic for biliary epithelial cells. Serum IgA was purified from six patients with PBC and its localization and ability to penetrate cells was studied using Madine-Darby canine kidney (MDCK) cells transfected with the human IgA receptor (MDCK-pIgR). The potential of IgA to be transported through the cells was studied by a combination of immunohistochemistry and dual color fluorescent microscopy. Interestingly, IgA from all PBC patients co-localized with PDC-E2 (the major autoantigen of PBC) inside the cells; this was demonstrated by dual staining with anti-human IgA and a mouse monoclonal antibody directed to PDC-E2. In contrast, no co-localization was observed for IgA controls. Furthermore, dual staining of liver sections from PBC patients demonstrated co-localization of IgA and PDC-E2, both cytoplasmically and at the apical surface. We postulate that there may be a direct effect of these autoantibodies on the mitochondrial function of biliary epithelial cells. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802945     DOI: 10.1006/jaut.1998.0220

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  16 in total

1.  Anti-mitochondria antibody-related tubulointerstitial nephritis accompanied by severe hypokalemic paralysis.

Authors:  Masashi Morita; Yoshito Yamaguchi; Satoshi Masuyama; Jun Nakamura; Sachio Kajimoto; Ryota Haga; Yu Yamanouchi; Katsuyuki Nagatoya; Hideaki Miwa; Atsushi Yamauchi
Journal:  CEN Case Rep       Date:  2019-01-14

2.  Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis.

Authors:  Toru Takahashi; Tomofumi Miura; Junichiro Nakamura; Satoshi Yamada; Tsutomu Miura; Masahiko Yanagi; Yasunobu Matsuda; Hiroyuki Usuda; Iwao Emura; Koichi Tsuneyama; Xiao-Song He; M Eric Gershwin
Journal:  Hepatology       Date:  2012-03       Impact factor: 17.425

3.  Low specificity of anti-tissue transglutaminase antibodies in patients with primary biliary cirrhosis.

Authors:  N Bizzaro; M Tampoia; D Villalta; S Platzgummer; M Liguori; R Tozzoli; E Tonutti
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

Review 4.  Autoantigens in primary biliary cirrhosis.

Authors:  D E Jones
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

Review 5.  A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis.

Authors:  Patrick S C Leung; Jinjung Choi; Guoxiang Yang; Elena Woo; Thomas P Kenny; M Eric Gershwin
Journal:  Expert Rev Mol Diagn       Date:  2016-03-30       Impact factor: 5.225

6.  IgG from patients with liver diseases inhibit mitochondrial respiration in permeabilized oxidative muscle cells: impaired function of intracellular energetic units?

Authors:  Lumme Kadaja; Kai E Kisand; Nadezhda Peet; Urmo Braun; Kaja Metsküla; Kaupo Teesalu; Riina Vibo; Kalle V Kisand; Raivo Uibo; Harald Jockusch; Enn K Seppet
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

Review 7.  Etiopathogenesis of primary biliary cirrhosis.

Authors:  Ana Lleo; Pietro Invernizzi; Ian-R Mackay; Harry Prince; Ren-Qian Zhong; M-Eric Gershwin
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

Review 8.  The X and why of xenobiotics in primary biliary cirrhosis.

Authors:  Roman Rieger; M Eric Gershwin
Journal:  J Autoimmun       Date:  2007-03-23       Impact factor: 7.094

Review 9.  The unfinished business of primary biliary cirrhosis.

Authors:  Carlo Selmi; Massimo Zuin; M Eric Gershwin
Journal:  J Hepatol       Date:  2008-07-02       Impact factor: 25.083

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.